Remegen
OverviewSuggest Edit
Remegen is a company that develops biopharmaceutical products. The company focuses on research and development, manufacturing and commercialization of biologics, notably monoclonal antibodies (mAb) and antibody-drug conjugates (ADCs), enabling patients and clinicians with pharmaceutical products for the treatment of cancer, autoimmune and eye-related diseases.
| Type | Private | |
| Founded | 2008 | |
| HQ | Yantai, CN | Map |
| Website | remegen.com |
Locations
Latest Updates
| Employees (est.) (Jan 2022) | 134 | (+4%) |
| Cybersecurity rating | A | More |
Key People/Management at Remegen
Jianmin Fang
Founder, CEO & CSO
Remegen Financials and Metrics
Summary Metrics
Founding Date | 2008 |
Remegen total Funding | $100 m |
Remegen latest funding size | $100 m |
Time since last funding | 2 years ago |
Remegen investors | Lilly Asia Ventures, Lake Bleu Capital |
Remegen's latest funding round in March 2020 was reported to be $100 m. In total, Remegen has raised $100 m
Remegen Cybersecurity Score
Remegen Online and Social Media Presence
Remegen's Trends
Remegen Frequently Asked Questions
When was Remegen founded?
Remegen was founded in 2008.
Who are Remegen key executives?
Remegen's key executives are Jianmin Fang.
How many employees does Remegen have?
Remegen has 134 employees.
Who are Remegen competitors?
Competitors of Remegen include Kahr medical, ChemoCentryx and Priothera.
Where are Remegen offices?
Remegen has an office in Yantai.
How many offices does Remegen have?
Remegen has 1 office.
Learn about Craft real-time company insights
Receive alerts for 300+ data fields across thousands of companies